Development and validation of a whole-cell ELISA for serologically diagnosing Helicobacter pylori infection in Brazilian children and adults: a diagnostic accuracy study

Bibliographic Details
Main Author: Ogata, Silvio Kazuo
Publication Date: 2018
Other Authors: Camorlinga-Ponce, Margarita, Granato, Celso Francisco Hernandes, Rohr, Maria Rachel da Silveira, Artigiani Neto, Ricardo, Kawakami, Elisabete
Format: Article
Language: eng
Source: São Paulo medical journal (Online)
Download full: https://periodicosapm.emnuvens.com.br/spmj/article/view/690
Summary: BACKGROUND: Serological tests are practical, with low cost, but no noninvasive tests are available for diagnosing Helicobacter pylori (H. pylori) infection in Brazil. The aim here was to develop and validate en‑ zyme‑linked immunosorbent assay (ELISA) serological tests to detect anti‑H. pylori immunoglobulin G an‑ tibodies, based on cultured strains from Brazilian patients. DESIGN AND SETTING: Cross‑sectional, diagnostic accuracy study comparing a locally developed and validated ELISA and invasive tests among dyspeptic patients at two public hospitals in São Paulo, Brazil. METHODS: An ELISA test was prepared using whole‑cell antigen from 56 strains. After genotypic charac‑ terization, it was standardized and optical density (OD) cutoffs were determined based on the serum an‑ tibody response of 100 H. pylori‑negative samples, compared with 82 H. pylori‑positive samples. Validation was performed on 174 symptomatic patients. RESULTS: The optimal OD cutoffs established (for monoclonal and polyclonal tests, respectively) were 0.167 and 0.164; overall ELISA sensitivity: 84.3%, 78.9%; specificity: 88.6%, 90.6%; positive predictive value (PPV): 75.4%, 80%; negative predictive value (NPV): 93.1%, 81.8%; accuracy: 87.3%, 86.2%; child and ad‑ olescent ELISA sensitivity: 74.2%, 81.8%; specificity: 90.8%, 86.7%; PPV: 66.6%, 84.3%; NPV: 95.8%, 84.8%; accuracy: 88.5%, 84.6; adult ELISA sensitivity: 84.4%, 75%; specificity: 86.9%, 93%; PPV: 81.8%, 78.3%; NPV: 88.9%, 91.8%; accuracy: 85.9%, 88.5%. CONCLUSION: The polyclonal serological test developed using local strains presented better diagnos‑ tic performance among children and adolescents, while the monoclonal test was better among adults. The results from both tests suggest that these in‑house serological tests could be used to detect anti‑H. pylori antibodies in our population, for screening purposes.
id APM-1_517d1e7329b646b1b2bf0ce5a2e29068
oai_identifier_str oai:ojs.diagnosticoetratamento.emnuvens.com.br:article/690
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Development and validation of a whole-cell ELISA for serologically diagnosing Helicobacter pylori infection in Brazilian children and adults: a diagnostic accuracy studyHelicobacter pyloriSerologyEnzyme‑linked immunosorbent assayChildAdultBACKGROUND: Serological tests are practical, with low cost, but no noninvasive tests are available for diagnosing Helicobacter pylori (H. pylori) infection in Brazil. The aim here was to develop and validate en‑ zyme‑linked immunosorbent assay (ELISA) serological tests to detect anti‑H. pylori immunoglobulin G an‑ tibodies, based on cultured strains from Brazilian patients. DESIGN AND SETTING: Cross‑sectional, diagnostic accuracy study comparing a locally developed and validated ELISA and invasive tests among dyspeptic patients at two public hospitals in São Paulo, Brazil. METHODS: An ELISA test was prepared using whole‑cell antigen from 56 strains. After genotypic charac‑ terization, it was standardized and optical density (OD) cutoffs were determined based on the serum an‑ tibody response of 100 H. pylori‑negative samples, compared with 82 H. pylori‑positive samples. Validation was performed on 174 symptomatic patients. RESULTS: The optimal OD cutoffs established (for monoclonal and polyclonal tests, respectively) were 0.167 and 0.164; overall ELISA sensitivity: 84.3%, 78.9%; specificity: 88.6%, 90.6%; positive predictive value (PPV): 75.4%, 80%; negative predictive value (NPV): 93.1%, 81.8%; accuracy: 87.3%, 86.2%; child and ad‑ olescent ELISA sensitivity: 74.2%, 81.8%; specificity: 90.8%, 86.7%; PPV: 66.6%, 84.3%; NPV: 95.8%, 84.8%; accuracy: 88.5%, 84.6; adult ELISA sensitivity: 84.4%, 75%; specificity: 86.9%, 93%; PPV: 81.8%, 78.3%; NPV: 88.9%, 91.8%; accuracy: 85.9%, 88.5%. CONCLUSION: The polyclonal serological test developed using local strains presented better diagnos‑ tic performance among children and adolescents, while the monoclonal test was better among adults. The results from both tests suggest that these in‑house serological tests could be used to detect anti‑H. pylori antibodies in our population, for screening purposes.São Paulo Medical JournalSão Paulo Medical Journal2018-10-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicosapm.emnuvens.com.br/spmj/article/view/690São Paulo Medical Journal; Vol. 136 No. 5 (2018); 442-448São Paulo Medical Journal; v. 136 n. 5 (2018); 442-4481806-9460reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APMenghttps://periodicosapm.emnuvens.com.br/spmj/article/view/690/631https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessOgata, Silvio KazuoCamorlinga-Ponce, MargaritaGranato, Celso Francisco HernandesRohr, Maria Rachel da SilveiraArtigiani Neto, RicardoKawakami, Elisabete2023-08-31T21:41:59Zoai:ojs.diagnosticoetratamento.emnuvens.com.br:article/690Revistahttp://www.scielo.br/spmjPUBhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2023-08-31T21:41:59São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Development and validation of a whole-cell ELISA for serologically diagnosing Helicobacter pylori infection in Brazilian children and adults: a diagnostic accuracy study
title Development and validation of a whole-cell ELISA for serologically diagnosing Helicobacter pylori infection in Brazilian children and adults: a diagnostic accuracy study
spellingShingle Development and validation of a whole-cell ELISA for serologically diagnosing Helicobacter pylori infection in Brazilian children and adults: a diagnostic accuracy study
Ogata, Silvio Kazuo
Helicobacter pylori
Serology
Enzyme‑linked immunosorbent assay
Child
Adult
title_short Development and validation of a whole-cell ELISA for serologically diagnosing Helicobacter pylori infection in Brazilian children and adults: a diagnostic accuracy study
title_full Development and validation of a whole-cell ELISA for serologically diagnosing Helicobacter pylori infection in Brazilian children and adults: a diagnostic accuracy study
title_fullStr Development and validation of a whole-cell ELISA for serologically diagnosing Helicobacter pylori infection in Brazilian children and adults: a diagnostic accuracy study
title_full_unstemmed Development and validation of a whole-cell ELISA for serologically diagnosing Helicobacter pylori infection in Brazilian children and adults: a diagnostic accuracy study
title_sort Development and validation of a whole-cell ELISA for serologically diagnosing Helicobacter pylori infection in Brazilian children and adults: a diagnostic accuracy study
author Ogata, Silvio Kazuo
author_facet Ogata, Silvio Kazuo
Camorlinga-Ponce, Margarita
Granato, Celso Francisco Hernandes
Rohr, Maria Rachel da Silveira
Artigiani Neto, Ricardo
Kawakami, Elisabete
author_role author
author2 Camorlinga-Ponce, Margarita
Granato, Celso Francisco Hernandes
Rohr, Maria Rachel da Silveira
Artigiani Neto, Ricardo
Kawakami, Elisabete
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Ogata, Silvio Kazuo
Camorlinga-Ponce, Margarita
Granato, Celso Francisco Hernandes
Rohr, Maria Rachel da Silveira
Artigiani Neto, Ricardo
Kawakami, Elisabete
dc.subject.por.fl_str_mv Helicobacter pylori
Serology
Enzyme‑linked immunosorbent assay
Child
Adult
topic Helicobacter pylori
Serology
Enzyme‑linked immunosorbent assay
Child
Adult
description BACKGROUND: Serological tests are practical, with low cost, but no noninvasive tests are available for diagnosing Helicobacter pylori (H. pylori) infection in Brazil. The aim here was to develop and validate en‑ zyme‑linked immunosorbent assay (ELISA) serological tests to detect anti‑H. pylori immunoglobulin G an‑ tibodies, based on cultured strains from Brazilian patients. DESIGN AND SETTING: Cross‑sectional, diagnostic accuracy study comparing a locally developed and validated ELISA and invasive tests among dyspeptic patients at two public hospitals in São Paulo, Brazil. METHODS: An ELISA test was prepared using whole‑cell antigen from 56 strains. After genotypic charac‑ terization, it was standardized and optical density (OD) cutoffs were determined based on the serum an‑ tibody response of 100 H. pylori‑negative samples, compared with 82 H. pylori‑positive samples. Validation was performed on 174 symptomatic patients. RESULTS: The optimal OD cutoffs established (for monoclonal and polyclonal tests, respectively) were 0.167 and 0.164; overall ELISA sensitivity: 84.3%, 78.9%; specificity: 88.6%, 90.6%; positive predictive value (PPV): 75.4%, 80%; negative predictive value (NPV): 93.1%, 81.8%; accuracy: 87.3%, 86.2%; child and ad‑ olescent ELISA sensitivity: 74.2%, 81.8%; specificity: 90.8%, 86.7%; PPV: 66.6%, 84.3%; NPV: 95.8%, 84.8%; accuracy: 88.5%, 84.6; adult ELISA sensitivity: 84.4%, 75%; specificity: 86.9%, 93%; PPV: 81.8%, 78.3%; NPV: 88.9%, 91.8%; accuracy: 85.9%, 88.5%. CONCLUSION: The polyclonal serological test developed using local strains presented better diagnos‑ tic performance among children and adolescents, while the monoclonal test was better among adults. The results from both tests suggest that these in‑house serological tests could be used to detect anti‑H. pylori antibodies in our population, for screening purposes.
publishDate 2018
dc.date.none.fl_str_mv 2018-10-04
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicosapm.emnuvens.com.br/spmj/article/view/690
url https://periodicosapm.emnuvens.com.br/spmj/article/view/690
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://periodicosapm.emnuvens.com.br/spmj/article/view/690/631
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv São Paulo Medical Journal
São Paulo Medical Journal
publisher.none.fl_str_mv São Paulo Medical Journal
São Paulo Medical Journal
dc.source.none.fl_str_mv São Paulo Medical Journal; Vol. 136 No. 5 (2018); 442-448
São Paulo Medical Journal; v. 136 n. 5 (2018); 442-448
1806-9460
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1825135058008145920